Lantern Pharma is trading at $1.30, up 6.56%, with no confirmed catalyst for the September 28 pre-market rise.
- No verified Lantern Pharma announcement explaining the move was found. Recent company news includes a September 22 patent notice, but it does not establish a cause.
- Major indices were lower in the supplied market context, so broad market strength does not explain the gain.